Edesa Biotech Inc

NASDAQ:EDSA   3:43:08 PM EDT
4.19
-0.26 (-5.80%)
5:59:52 PM EDT: $4.99 +0.80 (+19.05%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Edesa Biotech Inc Stock, NASDAQ:EDSA

100 Spy Court, Markham, Ontario L3R 5H6
Canada
Phone: +1.289.800.9600
Number of Employees: 16

Description

Edesa Biotech, Inc. is a biopharmaceutical company, which focuses on acquiring, developing, and commercializing clinical stage drugs for inflammatory and immune-related diseases. Its clinical studies include EB05 for Acute Respiratory Distress Syndrome (ARDS), EB07 for systemic sclerosis (SSc), EB01 for chronic Allergic Contact Dermatitis (ACD), EB02 for hemorrhoids, and EB06 for vitiligo. The company was founded by Pardeep Nijhawan on June 12, 2007 and is headquartered in Markham, Canada.